glp-1 drugs and muscle loss Glucagon-like peptide-1 receptor agonists mass effects Adverse effects of GLP-1 class

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin

Drugs like semaglutide and liraglutide have recently gained massive attention not just for diabetes, but for weight loss

Is berberine a GLP-1 agonist

Made in the USA

The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects